{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:15:33Z","timestamp":1791422133201,"version":"4.3.3"},"reference-count":118,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402396"],"award-info":[{"award-number":["81402396"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science-Technology Soft Sciences Project","award":["2016ZR0086"],"award-info":[{"award-number":["2016ZR0086"]}]},{"name":"Yi Yao Foundation","award":["14H0563"],"award-info":[{"award-number":["14H0563"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.canlet.2016.04.038","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T06:30:42Z","timestamp":1461997842000},"page":"174-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["Tumor microenvironment: The culprit for ovarian cancer metastasis?"],"prefix":"10.1016","volume":"377","author":[{"given":"Zhongyue","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne Bond","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuquan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2016.04.038_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.canlet.2016.04.038_bib0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10585-008-9171-5","article-title":"Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression","volume":"25","author":"Hudson","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2016.04.038_bib0020","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2016.04.038_bib0025","first-page":"541","article-title":"CLIC4 mediates TGF-beta1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer","volume":"22","author":"Yao","year":"2009","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.canlet.2016.04.038_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2011.01.011","article-title":"Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion","volume":"303","author":"Zhang","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2016.04.038_bib0035","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.04.038_bib0040","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/0008-5472.CAN-05-3260","article-title":"Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma","volume":"66","author":"Koukourakis","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yexmp.2009.09.001","article-title":"TGF-beta induces fibroblast activation protein expression; fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910PM [corrected]","volume":"87","author":"Chen","year":"2009","journal-title":"Exp. Mol. Pathol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0050","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.biocel.2004.12.002","article-title":"Potential oncogenic action of tenascin-C in tumorigenesis","volume":"37","author":"Orend","year":"2005","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0055","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.bjc.6690410","article-title":"Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines","volume":"80","author":"Wilson","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2016.04.038_bib0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1593\/neo.101720","article-title":"Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer","volume":"13","author":"Schauer","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2016.04.038_bib0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2528","article-title":"Trophic macrophages in development and disease","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"18","author":"Sica","year":"2008","journal-title":"Semin. Cancer Biol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0080","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2016.04.038_bib0085","first-page":"445","article-title":"Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival","volume":"17","author":"Lissbrant","year":"2000","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0090","first-page":"425","article-title":"Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density","volume":"14","author":"Tsutsui","year":"2005","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.canlet.2016.04.038_bib0095","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/j.1349-7006.2010.01652.x","article-title":"Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation","volume":"101","author":"Takaishi","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.canlet.2016.04.038_bib0100","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1172\/JCI117933","article-title":"The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer","volume":"95","author":"Negus","year":"1995","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2016.04.038_bib0105","first-page":"999","article-title":"Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1","volume":"3","author":"Chambers","year":"1997","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1440-1827.2009.02369.x","article-title":"Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors","volume":"59","author":"Kawamura","year":"2009","journal-title":"Pathol. Int"},{"key":"10.1016\/j.canlet.2016.04.038_bib0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7785\/tcrt.2012.500312","article-title":"Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer","volume":"12","author":"Lan","year":"2013","journal-title":"Technol. Cancer Res. Treat"},{"key":"10.1016\/j.canlet.2016.04.038_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038541","article-title":"BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis","volume":"7","author":"Le Page","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.04.038_bib0125","doi-asserted-by":"crossref","first-page":"8900","DOI":"10.1158\/0008-5472.CAN-07-1866","article-title":"Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma","volume":"67","author":"Kryczek","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0130","first-page":"121","article-title":"Bioactive interleukin-6 levels in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer","volume":"39","author":"Gastl","year":"2001","journal-title":"Methods Mol. Med"},{"key":"10.1016\/j.canlet.2016.04.038_bib0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cyto.2008.10.019","article-title":"Monitoring of IL-10 in the serum of patients with advanced ovarian cancer: results from a prospective pilot-study","volume":"45","author":"Mustea","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.canlet.2016.04.038_bib0140","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4049\/jimmunol.175.2.1197","article-title":"Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK","volume":"175","author":"Hagemann","year":"2005","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0145","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.4049\/jimmunol.1203194","article-title":"Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer","volume":"190","author":"Neyen","year":"2013","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0150","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/cas.12110","article-title":"Interaction of monocytes\/macrophages with ovarian cancer cells promotes angiogenesis in vitro","volume":"104","author":"Wang","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.canlet.2016.04.038_bib0155","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med"},{"key":"10.1016\/j.canlet.2016.04.038_bib0160","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20050930","article-title":"B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma","volume":"203","author":"Kryczek","year":"2006","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.canlet.2016.04.038_bib0165","doi-asserted-by":"crossref","first-page":"547179","DOI":"10.1155\/2010\/547179","article-title":"Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages","volume":"2010","author":"Allavena","year":"2010","journal-title":"Clin. Dev. Immunol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0170","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ygyno.2009.11.020","article-title":"Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype","volume":"116","author":"Barnett","year":"2010","journal-title":"Gynecol. Oncol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0175","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2013.08.025","article-title":"Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2","volume":"39","author":"Cui","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2016.04.038_bib0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nri3605","article-title":"Homeostatic control of regulatory T cell diversity","volume":"14","author":"Liston","year":"2014","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0185","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0190","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0195","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1593\/tlo.13529","article-title":"Epithelial ovarian cancer-induced angiogenic phenotype of human omental microvascular endothelial cells may occur independently of VEGF signaling","volume":"6","author":"Winiarski","year":"2013","journal-title":"Transl. Oncol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0200","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1083\/jcb.200302047","article-title":"VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia","volume":"161","author":"Gerhardt","year":"2003","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0205","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ceb.2010.08.010","article-title":"Dynamics of endothelial cell behavior in sprouting angiogenesis","volume":"22","author":"Eilken","year":"2010","journal-title":"Curr. Opin. Cell Biol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","article-title":"What is the evidence that tumors are angiogenesis dependent?","volume":"82","author":"Folkman","year":"1990","journal-title":"J. Natl Cancer Inst"},{"key":"10.1016\/j.canlet.2016.04.038_bib0215","first-page":"1105","article-title":"Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms","volume":"74","author":"Abu-Jawdeh","year":"1996","journal-title":"Lab. Invest"},{"key":"10.1016\/j.canlet.2016.04.038_bib0220","first-page":"823","article-title":"Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy","volume":"5","author":"Hazelton","year":"1999","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0225","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/jnci\/93.10.734","article-title":"A new link in ovarian cancer angiogenesis: lysophosphatidic acid and vascular endothelial growth factor expression","volume":"93","author":"Folkman","year":"2001","journal-title":"J. Natl Cancer Inst"},{"key":"10.1016\/j.canlet.2016.04.038_bib0230","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9378(97)70143-1","article-title":"Angiogenesis in primary and metastatic epithelial ovarian carcinoma","volume":"177","author":"Abulafia","year":"1997","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0235","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7314\/APJCP.2015.16.3.869","article-title":"Microvessel density as a prognostic factor in ovarian cancer: a systematic review and meta-analysis","volume":"16","author":"He","year":"2015","journal-title":"Asian Pac. J. Cancer Prev"},{"key":"10.1016\/j.canlet.2016.04.038_bib0240","first-page":"548","article-title":"Angiogenesis in early-invasive and low-malignant-potential epithelial ovarian carcinoma","volume":"95","author":"Abulafia","year":"2000","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0245","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.RES.0000182903.16652.d7","article-title":"Endothelial\/pericyte interactions","volume":"97","author":"Armulik","year":"2005","journal-title":"Circ. Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2016.04.038_bib0255","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1073\/pnas.1015449108","article-title":"Dual origin of mesenchymal stem cells contributing to organ growth and repair","volume":"108","author":"Feng","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.04.038_bib0260","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI200317929","article-title":"Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors","volume":"111","author":"Bergers","year":"2003","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2016.04.038_bib0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.11.024","article-title":"Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway","volume":"21","author":"Cooke","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2016.04.038_bib0270","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1172\/JCI25705","article-title":"Pericytes limit tumor cell metastasis","volume":"116","author":"Xian","year":"2006","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2016.04.038_bib0275","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1158\/1078-0432.CCR-15-1931","article-title":"Pericytes promote malignant ovarian cancer progression in mice and predict poor prognosis in serous ovarian cancer patients","volume":"22","author":"Sinha","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0280","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canlet.2016.04.038_bib0285","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.seminoncol.2014.04.004","article-title":"Platelet effects on ovarian cancer","volume":"41","author":"Davis","year":"2014","journal-title":"Semin. Oncol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0290","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00404-008-0673-9","article-title":"The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors","volume":"279","author":"Gungor","year":"2009","journal-title":"Arch. Gynecol. Obstet"},{"key":"10.1016\/j.canlet.2016.04.038_bib0295","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10585-009-9264-9","article-title":"Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis","volume":"26","author":"Holmes","year":"2009","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2016.04.038_bib0300","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nbt.2576","article-title":"Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay","volume":"31","author":"Baccelli","year":"2013","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0305","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12885-015-1304-z","article-title":"Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells","volume":"15","author":"Orellana","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2016.04.038_bib0310","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.yexcr.2011.01.005","article-title":"Chemokines in health and disease","volume":"317","author":"Raman","year":"2011","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0315","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1158\/0008-5472.CAN-06-2941","article-title":"The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells","volume":"67","author":"Kulbe","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1677\/erc.0.0060093","article-title":"The role of cytokines in both the normal and malignant ovary","volume":"6","author":"Nash","year":"1999","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canlet.2016.04.038_bib0325","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2016.04.038_bib0330","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2006.02.036","article-title":"Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression","volume":"103","author":"Jiang","year":"2006","journal-title":"Gynecol. Oncol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0335","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1158\/0008-5472.CAN-11-2178","article-title":"A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment","volume":"72","author":"Kulbe","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0340","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-alpha in promotion and progression of cancer","volume":"25","author":"Balkwill","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.canlet.2016.04.038_bib0345","first-page":"745","article-title":"Distinct expression and localization of TNF system in ovarian carcinoma tissues: possible involvement of TNF-alpha in morphological changes of ovarian cancerous cells","volume":"34","author":"Piura","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0350","first-page":"4961","article-title":"Epithelial cancer cell migration: a role for chemokine receptors?","volume":"61","author":"Scotton","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0355","first-page":"5930","article-title":"Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer","volume":"62","author":"Scotton","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0360","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ijc.23083","article-title":"Involvement of SDF-1alpha\/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma","volume":"122","author":"Kajiyama","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2016.04.038_bib0365","first-page":"117","article-title":"Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications","volume":"1845","author":"Kumar","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2016.04.038_bib0370","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/bjc.1995.71","article-title":"Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer","volume":"71","author":"Scambia","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2016.04.038_bib0375","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2007.14.1978","article-title":"Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients","volume":"26","author":"Lutgendorf","year":"2008","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0380","first-page":"337","article-title":"Effects of interleukin-6 on in vitro cell attachment, migration and invasion of human ovarian carcinoma","volume":"17","author":"Obata","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0385","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1038\/onc.2011.572","article-title":"Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer","volume":"31","author":"Alberti","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2016.04.038_bib0390","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cyto.2012.04.020","article-title":"Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells","volume":"59","author":"Wang","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.canlet.2016.04.038_bib0395","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1083\/jcb.201102147","article-title":"The extracellular matrix: a dynamic niche in cancer progression","volume":"196","author":"Lu","year":"2012","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0400","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1158\/1078-0432.CCR-03-0103","article-title":"Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer","volume":"10","author":"Davies","year":"2004","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0405","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/scdb.2000.0241","article-title":"Heparan sulfate proteoglycans in invasion and metastasis","volume":"12","author":"Sanderson","year":"2001","journal-title":"Semin. Cell Dev. Biol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0410","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.yexcr.2010.11.017","article-title":"Hyaluronan in human malignancies","volume":"317","author":"Sironen","year":"2011","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0415","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-3835(02)00037-X","article-title":"Expression of hyaluronate and hyaluronate synthase in human primary tumours and their metastases in scid mice","volume":"188","author":"Jojovic","year":"2002","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2016.04.038_bib0420","first-page":"150","article-title":"High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer","volume":"60","author":"Anttila","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0425","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s13277-012-0369-4","article-title":"Cell surface expression of hyaluronan on human ovarian cancer cells inversely correlates with their adhesion to peritoneal mesothelial cells","volume":"33","author":"Tamada","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0430","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1158\/1078-0432.CCR-05-2338","article-title":"The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer","volume":"12","author":"Kamat","year":"2006","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0435","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00404-012-2456-6","article-title":"Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion","volume":"286","author":"Hu","year":"2012","journal-title":"Arch. Gynecol. Obstet"},{"key":"10.1016\/j.canlet.2016.04.038_bib0440","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jnci\/94.15.1134","article-title":"Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice","volume":"94","author":"Huang","year":"2002","journal-title":"J. Natl Cancer Inst"},{"key":"10.1016\/j.canlet.2016.04.038_bib0445","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2016.04.038_bib0450","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcancer.2010.05.002","article-title":"Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion","volume":"20","author":"Bourboulia","year":"2010","journal-title":"Semin. Cancer Biol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0455","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/IGC.0000000000000386","article-title":"The expression of tumor-derived and stromal-derived matrix metalloproteinase 2 predicted prognosis of ovarian cancer","volume":"25","author":"Fu","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.canlet.2016.04.038_bib0460","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3892\/or.2012.2148","article-title":"Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance","volume":"29","author":"Zhang","year":"2013","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.canlet.2016.04.038_bib0465","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ijc.1215","article-title":"Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)","volume":"92","author":"Borgfeldt","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2016.04.038_bib0470","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1593\/neo.12442","article-title":"Differential roles of uPAR in peritoneal ovarian carcinomatosis","volume":"14","author":"Al-Hassan","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2016.04.038_bib0475","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1593\/neo.08178","article-title":"Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles","volume":"10","author":"Giusti","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2016.04.038_bib0480","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3892\/or.2014.2967","article-title":"Overexpression of cysteine cathepsin L is a marker of invasion and metastasis in ovarian cancer","volume":"31","author":"Zhang","year":"2014","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.canlet.2016.04.038_bib0485","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tranon.2014.02.013","article-title":"Clinical relevance of increased endothelial and mesothelial expression of proangiogenic proteases and VEGFA in the omentum of patients with metastatic ovarian high-grade serous carcinoma","volume":"7","author":"Winiarski","year":"2014","journal-title":"Transl. Oncol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0490","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1023\/A:1008352502465","article-title":"The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer","volume":"10","author":"Baekelandt","year":"1999","journal-title":"Ann. Oncol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0495","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/bjc.1998.737","article-title":"Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome","volume":"78","author":"Ferrandina","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2016.04.038_bib0500","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00404-012-2318-2","article-title":"The potential prognostic value of cathepsin D protein in serous ovarian cancer","volume":"286","author":"Chai","year":"2012","journal-title":"Arch. Gynecol. Obstet"},{"key":"10.1016\/j.canlet.2016.04.038_bib0505","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1254\/jjp.75.215","article-title":"Cell adhesion molecules and cancer metastasis","volume":"75","author":"Saiki","year":"1997","journal-title":"Jpn J. Pharmacol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0510","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2016.04.038_bib0515","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10585-014-9658-1","article-title":"Ascites-induced shift along epithelial-mesenchymal spectrum in ovarian cancer cells: enhancement of their invasive behavior partly dependant on alphav integrins","volume":"31","author":"Carduner","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2016.04.038_bib0520","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11010-013-1671-1","article-title":"Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by alphavbeta6 integrin-mediated signaling in ovarian cancer","volume":"380","author":"Xue","year":"2013","journal-title":"Mol. Cell. Biochem"},{"key":"10.1016\/j.canlet.2016.04.038_bib0525","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0002-9440(10)63058-1","article-title":"Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids","volume":"159","author":"Casey","year":"2001","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0530","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/onc.2010.532","article-title":"Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis","volume":"30","author":"Mitra","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2016.04.038_bib0535","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00404-012-2684-9","article-title":"Prognostic role of E-cadherin in patients with advanced serous ovarian cancer","volume":"287","author":"Bacic","year":"2013","journal-title":"Arch. Gynecol. Obstet"},{"key":"10.1016\/j.canlet.2016.04.038_bib0540","first-page":"1228","article-title":"In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation","volume":"57","author":"Strobel","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0545","first-page":"1073","article-title":"Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival","volume":"5","author":"Kayastha","year":"1999","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0550","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1309\/KUK0-1M3D-LGNE-THXR","article-title":"Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas","volume":"116","author":"Ross","year":"2001","journal-title":"Am. J. Clin. Pathol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0555","first-page":"5318","article-title":"CD44 expression indicates favorable prognosis in epithelial ovarian cancer","volume":"9","author":"Sillanpaa","year":"2003","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0560","doi-asserted-by":"crossref","first-page":"36691","DOI":"10.1074\/jbc.M113.512806","article-title":"Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling","volume":"288","author":"Bretz","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2016.04.038_bib0565","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00262-011-0979-5","article-title":"Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC","volume":"60","author":"Battke","year":"2011","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1016\/j.canlet.2016.04.038_bib0570","first-page":"749","article-title":"Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity","volume":"25","author":"Peng","year":"2011","journal-title":"Oncol. Rep"},{"key":"10.1016\/j.canlet.2016.04.038_bib0575","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2011.08.005","article-title":"Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts","volume":"123","author":"Cho","year":"2011","journal-title":"Gynecol. Oncol"},{"key":"10.1016\/j.canlet.2016.04.038_bib0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038340","article-title":"Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties","volume":"7","author":"Lis","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.04.038_bib0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011469","article-title":"Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg)","volume":"5","author":"Szajnik","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2016.04.038_bib0590","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1158\/1078-0432.CCR-04-1688","article-title":"Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells","volume":"11","author":"Gutwein","year":"2005","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2016.04.038_bib0595","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2007.08.064","article-title":"Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM","volume":"107","author":"Runz","year":"2007","journal-title":"Gynecol. Oncol"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516302749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516302749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T05:24:25Z","timestamp":1567833865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383516302749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0304383516302749"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2016.04.038","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor microenvironment: The culprit for ovarian cancer metastasis?","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2016.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}